Taking both Spiriva and Symbicort gives you three different medications working through three different mechanisms to open your airways and reduce inflammation. Symbicort already contains two active drugs: an inhaled steroid that calms airway inflammation and a long-acting bronchodilator that relaxes the muscles around your airways. Spiriva adds a third drug that relaxes those same muscles through an entirely different pathway. This “triple therapy” approach is prescribed when two medications alone aren’t keeping symptoms under control.
How Each Inhaler Works Differently
Symbicort combines two types of medication. The steroid component (budesonide) reduces the swelling and mucus production inside your airways over time. The bronchodilator component (formoterol) works by stimulating receptors on the smooth muscle surrounding your airways, causing that muscle to relax and the airways to widen. Formoterol acts quickly and lasts about 12 hours, which is why Symbicort is taken twice daily, morning and evening.
Spiriva contains tiotropium, which opens airways through a completely separate mechanism. Instead of stimulating muscles to relax, it blocks the signals that tell those muscles to tighten in the first place. These are two distinct biological pathways, so combining them produces more airway opening than either one alone. Think of it like loosening a tight lid by both pushing from one direction and pulling from another.
Why Two Bronchodilators Are Better Than One
When you have moderate to severe COPD, or asthma that doesn’t respond well to a steroid-plus-bronchodilator inhaler, a single bronchodilator often can’t keep your airways open enough throughout the day. Adding Spiriva to Symbicort has been shown to produce measurable improvements in lung function. In studies of patients already on budesonide and formoterol, adding tiotropium increased the volume of air they could forcefully exhale in one second (a standard measure of lung capacity) by a small but statistically significant amount.
Beyond raw lung function numbers, the practical benefits matter more to most people: fewer flare-ups, less shortness of breath during daily activities, and better symptom control overnight and in the early morning when airways tend to be at their tightest. The goal of triple therapy is to reduce the frequency and severity of exacerbations, those episodes where symptoms suddenly worsen and sometimes lead to emergency care or hospitalization.
When Triple Therapy Is Recommended
For COPD, doctors typically start with one or two inhaled medications and step up treatment if symptoms persist. Triple therapy becomes the next move when you’re still experiencing frequent flare-ups, significant breathlessness, or declining lung function despite using a dual-therapy inhaler consistently and correctly.
For asthma, the picture is similar but the thresholds are defined more precisely by international treatment guidelines. Long-acting muscarinic antagonists like Spiriva are recommended as an add-on option at step 4 (moderate-to-severe persistent asthma) and as a first-choice addition at step 5 (the most severe category). Among lung specialists, roughly 90% agree that optimizing inhaled therapy with this kind of combination should be tried before moving to injectable biologic drugs, which are more expensive and more involved. Patients with persistent airflow limitation and those who show strong reversibility on breathing tests tend to respond best to the addition of Spiriva.
How to Take Both Inhalers
Symbicort is taken as two puffs twice a day, roughly 12 hours apart. After each dose, you should rinse your mouth with water and spit it out. This prevents the steroid from lingering in your mouth and throat, which can cause a fungal infection called thrush.
Spiriva is typically taken once daily, usually in the morning, since its effects last a full 24 hours. There’s no strict rule about spacing the two inhalers apart. Many people take their morning Symbicort and their Spiriva around the same time. If you’re using both during the same session, wait about a minute between inhalers to let the first medication settle into your airways before inhaling the second.
Side Effects of the Combination
One advantage of combining these specific medications is that there are no direct drug interactions between them. They work through separate pathways and don’t interfere with each other’s absorption or activity. But you are taking three active drugs, so the list of potential side effects is longer than with either inhaler alone.
Spiriva’s most common nuisance side effect is dry mouth, which comes from its anticholinergic action. That same mechanism means it can worsen narrow-angle glaucoma or urinary retention in people who are already prone to those conditions. If aerosolized medication accidentally contacts your eyes, it can temporarily raise pressure inside the eye.
The formoterol in Symbicort can occasionally cause a rapid heartbeat, palpitations, or a slight drop in potassium levels. These effects are uncommon at standard doses but are worth knowing about if you have underlying heart disease. The budesonide component, like all inhaled steroids, slightly increases susceptibility to oral thrush and throat irritation. Over very long periods of use, inhaled steroids can also contribute to cataracts or elevated eye pressure, though these risks are much lower than with oral steroids.
Most people tolerate the combination well. The side effects that do occur are generally mild: dry mouth, occasional hoarseness, or a slightly scratchy throat. Rinsing after Symbicort and staying hydrated throughout the day addresses the most common complaints.
Cost and Generic Options
Cost is a real consideration with triple therapy since you’re filling two separate inhaler prescriptions. A generic version of Symbicort (budesonide/formoterol) was approved by the FDA in March 2022, which has brought prices down for many patients. Spiriva remains more expensive, though tiotropium is available in both a soft-mist inhaler and a dry-powder capsule form, and pricing varies between the two. Checking with your insurance plan or using manufacturer discount programs can significantly reduce out-of-pocket costs for the combination.
Some manufacturers now offer all three medications in a single inhaler device, which simplifies the routine and can be cheaper than filling two separate prescriptions. Your doctor can help determine whether a single triple-therapy inhaler or the two-inhaler approach makes more sense based on your insurance coverage and the specific doses you need.